Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofol vs sevoflurane vs propofol for postoperative nausea and vomiting in gynecologic laparoscopy
ChiCTR2400086361Phase 4Not yet recruiting
- Sponsor
- Baoding No. 1 Central Hospital
- Start
- Jun 2024
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ciprofol in postoperative nausea and vomiting (PONV) (3 arms), sponsored by Baoding No. 1 Central Hospital. Primary endpoint: Incidence of postoperative nausea and vomiting within 24 hours. Planned start Jun 2024; status: not yet recruiting.
02
Drugs
ciprofol
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on ChiCTR2400086361.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400086361.